Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit

Journal of Allergy and Clinical Immunology

Volumn 109, Issue 6, 2002, Pages 956-961

  Horak, Friedrich ^a   Stübner, Ursula P ^c   Zieglmayer, Rene ^c   Harris, Alan G ^c  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE   (Austria)

^c NONE

Author keywords

Allergen exposure; Antihistamine; Desloratadine; Nasal obstruction; Rhinomanometry; Seasonal allergic rhinitis

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ASTEMIZOLE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; DESLORATADINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; TETRACYCLIC ANTIDEPRESSANT AGENT;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DYSMENORRHEA; FEMALE; GRASS POLLEN; HUMAN; MALE; MIGRAINE; NOSE AIRFLOW; NOSE CONGESTION; NOSE OBSTRUCTION; NOSE SECRETION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SNEEZING; SOMNOLENCE; VIRUS INFECTION;

EID: 0036279872     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.124657     Document Type: Article

References (24)

1. Management of allergic rhinitis: Antihistamines and decongestants
2. Allergy and allergic diseases (Part 1 of 2)
3. Effect of leukotriene D4 on nasal mucosa blood flow, nasal airway resistance and nasal secretion in humans
4. Effect of H1 and H2 antagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season
5. Adrenoreceptors in the control of human nasal mucosa blood flow
6. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: Receptor selectivity, antihistaminic activity, and antiallergic effects
7. Efficacy and tolerability of once-daily desloratadine, an H1-receptor antagonist, in patients with seasonal allergic rhinitis
8. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis
9. Die wiener provokations kammer (Vienna Challenge Chamber) - Eine neue methode des allergenexpositionstests
10. Effects of H1-receptor antagonists on nasal obstruction in atopic patients
11. Safety and efficacy of loratadine (Sch-29851): A new non-sedating antihistamine in seasonal allergic rhinitis
12. Clinical studies with cetirizine in allergic rhinitis and chronic urticaria
13. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials
14. The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis
15. Budesonide and nasal allergen testing in man
16. Effects of high doses of topical steroids on both ragweed and histamine-induced nasal provocation
17. Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate spray
18. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis
19. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis
20. Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg O.D. In reducing symptoms of seasonal allergic rhinitis
21. Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-release pseudoephedrine in the management of nasal congestion
22. Desloratadine: A new, nonsedating, oral antihistamine